Post-approval studies (Phase 4)Ended earlyNCT01796548
What this trial is testing
Extended-Release Oxybutynin for the Treatment of Neurogenic Detrusor Overactivity
Who this might be right for
Detrusor Function, Overactive
Janssen-Cilag Ltd.,Thailand 17